Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
30%(3 trials)

Phase Distribution

Ph not_applicable
10
77%
Ph phase_2
1
8%
Ph phase_3
1
8%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Other(2)

Detailed Status

Completed10
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 41 (7.7%)
N/A10 (76.9%)

Trials by Status

unknown215%
not_yet_recruiting18%
completed1077%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13